New Breast Cancer Clinical Trial
Research –making a difference. PCI is pleased to announce we are the first center in the US to be able to offer a new breast cancer clinical trial for women or men with advanced or metastatic breast cancer. The Phase 2 trial will compare the use of capecitabine with one of two different monoclonal antibodies.
For more information about the trial contact our research department at 678-298-3235